Form 8-K - Current report:
SEC Accession No. 0001561743-19-000049
Filing Date
2019-07-30
Accepted
2019-07-29 17:33:47
Documents
2
Period of Report
2019-07-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjuly292019.htm 8-K 30411
2 EXHIBIT 99.1 pressreleasejuly292019.htm EX-99.1 14797
  Complete submission text file 0001561743-19-000049.txt   46295
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 19982551
SIC: 2834 Pharmaceutical Preparations